Home › Meningioma › New York › New York City
Meningioma clinical trials in New York City, NY
8 studies for Meningioma are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
RecruitingPhase 2
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Weill Cornell Medical Center, New York
Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
RecruitingPhase 2
- NYU Lagone Health, New York
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
RecruitingPhase 2
- Memorial Sloan-Kettering Cancer Center, New York
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
RecruitingPhase 2
- New York University Langone Medical Center, New York
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
RecruitingPhase 2
- NYU- Langone Health, New York
Cabozantinib for Patients With Recurrent or Progressive Meningioma
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
RecruitingPhase 4
- New York-Presbyterian/Weill Cornell Medical Center, New York
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
RecruitingPhase 4
- Weill Cornell Medicine, New York
Meningioma trials in other cities
- Miami, FL7 studies
- Boston, MA6 studies
- Columbus, OH6 studies
- Jacksonville, FL5 studies
- San Francisco, CA5 studies
- Atlanta, GA5 studies
- San Diego, CA5 studies
- Phoenix, AZ4 studies
- Arlington, VA4 studies
- Houston, TX4 studies
- Detroit, MI4 studies
- St. Louis, MO3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.